SCHEMBL6316355

SCHEMBL6316355

CCCCNC(=O)c1c(-c2ccccn2)noc1NS(=O)(=O)c1cccs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44
EDNRA P25101 1/20 0.43
ALDH1A1 P00352 5/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
NPY5R Q15761 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 2/20 0.39
RECQL P46063 1/20 0.39
GAA P10253 2/20 0.38
MMP2 P08253 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HPGD P15428 1/20 0.37
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316498 0.86 GAA (0.43) KDM4EHSD17B10EDNRAALDH1A1MEN1
SCHEMBL6324666 0.86 GAA (0.42) KDM4EHSD17B10EDNRAALDH1A1MEN1
SCHEMBL6318163 0.84 EDNRA (0.43) KDM4EHSD17B10USP2EDNRAALDH1A1
SCHEMBL6315797 0.83 KDM4E (0.51) KDM4EHSD17B10EDNRAALDH1A1MEN1
SCHEMBL6315903 0.82 KDM4E (0.50) KDM4EHSD17B10EDNRAALDH1A1MEN1
SCHEMBL6315769 0.82 L3MBTL1 (0.42) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL6315466 0.80 NAAA (0.47) ALDH1A1MEN1KMT2AMAPTL3MBTL1
SCHEMBL6322628 0.79 HTT (0.45) GAAHTTSMN1; SMN2
SCHEMBL6323422 0.78 HTT (0.46) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL6325190 0.78 HTT (0.46) MEN1KMT2AL3MBTL1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 KDM4E 1382/4885HSD17B10 4152/4885USP2 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.